Alembic Pharma gets USFDA nod for hypertension treatment drug
Alembic Pharma Share Price | These capsules will be available in dosages of 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg, offering…
Latest News
Analyst recommends buying Cummins, BEL and selling Coal India, Bharat Forge in today’s trade
Market tech analyst Mitessh Thakkar have these recommendations on Monday.
Inox India bags order to build mini LNG terminal in The Bahamas
Inox India Share Price | The project, located on Arawak Cay near Nassau Cruise Port, is designed to support IPP’s 60 MW combined-cycle power plant,…
Aarti Industries share price drops to a 52-week low after 17% fall in three sessions — Explained
A sharp dip in margins of its key product Mono Methyl Aniline (MMA) impacted Aarti Industries’ quarterly performance. MMA volumes fell by 35% sequentially, impacting…
CNBC-TV18 Morning Call: Tata Motors and OLA Electric results disappoint, Asian Paints delivers volume dip
From CCI probe against Swiggy and Zomato, Swiggy IPO subscription to Tata Motors and Ola Electric’s earnings disappointment and more, here is all that you…
Marketbuzz Podcast With Hormaz Fatakia: 24,000 key for Nifty; Another earnings accident from Asian Paints
Marketbuzz Podcast: Indian markets may open in the red according to the GIFT Nifty. Watch out for stocks like Asian Paints, Tata Motors, Ola Electric…
PFC shares can surge up to ₹680, say analysts, expecting stock to cross previous record high
DAM Capital has the highest price target on PFC at ₹680, followed by UBS at ₹670.
Reliance Industries shares are now down 20% from their peak — Is it time to buy?
Reliance Industries, over the last one month has declined 8% and has been one of the key underperformers on the Nifty 50 index and among…
Chinese stocks face pressure as fiscal stimulus underwhelms
Beijing announced a 10 trillion yuan ($1.4 trillion) program to help local governments tackle their hidden debt on Friday but stopped short of providing new…
Tata Motors shares get multiple target cuts as analysts trim elevated estimates post Q2 results
UBS said that JLR’s management has maintained its margin guidance but that is contingent to demand not worsening any further amidst industry profit warnings.